Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rates » significant facies (Expand Search), significant role (Expand Search), significant risks (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rates » significant facies (Expand Search), significant role (Expand Search), significant risks (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), greater decrease (Expand Search)
-
1141
-
1142
-
1143
-
1144
-
1145
-
1146
Results obtained from different regression models along with their respective AIC values.
Published 2025Subjects: -
1147
Descriptive statistics for the number of under five children death per 100 mothers.
Published 2025Subjects: -
1148
-
1149
-
1150
Burden and trends of LC in the chinese annual cancer registry in 2004 and 2018.
Published 2025Subjects: -
1151
-
1152
-
1153
-
1154
Projected ASIR and ASMR of LC in China over the next 15 years based on the Bayesian APC model.
Published 2025Subjects: -
1155
-
1156
-
1157
-
1158
Changes in the active H3K27ac and repressive H3K27me3 histone marks among Vasa2+/Piwi1+ and all cells in fed, starved, and refed juvenile polyps.
Published 2025“…Between fed, T<sub>5ds</sub> and T<sub>20ds</sub> timepoints, MFI levels of H3K27ac progressively and significantly decreased while levels H3K27me3 (M) did not change significantly (N). …”
-
1159
-
1160
The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells.
Published 2025“…<i>n</i> = 2–4 biological replicates per condition, with 15 individuals per replicate. Significance levels for Student <i>t</i> test are indicated for adjusted <i>p</i> values: *<i>p</i> < 0.05, ***<i>p</i> < 0.001, ***<i>p</i> < 0.0001. d: day(s), n.s.: non-significant. …”